专题：Breast Cancer Treatment Studies

This cluster of papers focuses on molecular research, treatment response, and prognostic markers in breast cancer. It covers topics such as gene expression patterns, molecular subtypes, neoadjuvant therapy, radiotherapy, and the impact of hormone receptors on survival. The papers also discuss the development of clinical practice guidelines for breast cancer management.
最新文献
Classification of Invasive Lobular Carcinoma

letter Full Text OpenAlex

Associations of Breast Cancer Method of Detection With Tumor Characteristics, Treatments, and Overall Survival: A Propensity-Score Matched Analysis

article Full Text OpenAlex

Abstract GS2-03: Does postmastectomy radiotherapy in 'intermediate-risk' breast cancer impact overall survival? 10 year results of the BIG 2-04 MRC SUPREMO randomised trial: on behalf of the SUPREMO trial investigators

article Full Text OpenAlex

Abstract GS3-09: Multimodal integration of real world clinical and genomic data for the prediction of CDK4/6 inhibitors outcomes in patients with HR+/HER2- metastatic breast cancer

article Full Text OpenAlex

Breast cancer in women after withdrawing from an increased-risk MRI screening program

article Full Text OpenAlex

Partial-breast radiotherapy after breast conservation surgery for women with early breast cancer (UK IMPORT LOW): 10-year outcomes from a multicentre, open-label, randomised, controlled, phase 3, non-inferiority trial

article Full Text OpenAlex

Overdiagnosis, competing morbidity and tumour biology in older women with breast cancer: building a case for active monitoring

review Full Text OpenAlex

Adjuvant Radiation vs Endocrine Therapy After Lumpectomy for Early-Stage Breast Cancer in Older Women: Analysis of Real-World Survival Outcomes

article Full Text OpenAlex

ASO Visual Abstract: Adjuvant Radiation Versus Endocrine Therapy After Lumpectomy for Early Stage Breast Cancer in Older Women—Analysis of Real-World Survival Outcomes

article Full Text OpenAlex

Omitting Regional Nodal Irradiation after Response to Neoadjuvant Chemotherapy

article Full Text OpenAlex

近5年高被引文献
Breast Cancer Statistics, 2022

article Full Text OpenAlex 1817 FWCI264.014

Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer

article Full Text OpenAlex 1369 FWCI129.28

Breast Cancer—Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies—An Updated Review

review Full Text OpenAlex 1257 FWCI33.289

Breast cancer

review Full Text OpenAlex 1199 FWCI48.634

ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer

article Full Text OpenAlex 942 FWCI128.074

Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

article Full Text OpenAlex 805 FWCI100.088

Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline

article Full Text OpenAlex 735 FWCI60.472

Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer

article Full Text OpenAlex 701 FWCI91.473

Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021

review Full Text OpenAlex 636 FWCI19.128

Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer

article Full Text OpenAlex 518 FWCI103.076